Literature DB >> 26898451

USO1 promotes tumor progression via activating Erk pathway in multiple myeloma cells.

Yueling Jin1, Zhensheng Dai2.   

Abstract

OBJECTIVE: This study aimed to explore the influence of USO1 on multiple myeloma (MM) cell proliferation and apoptosis and the related molecular mechanism.
METHODS: The expression of USO1 and MIF in MM tissues and cells, normal bone marrow tissues and cells were determined by qRT-PCR and western blot assay. The cell proliferation and apoptosis of MM cells before and after knockdown of USO1 were determined by MTT assay and flow cytometry, respectively. Before and after knockdown of USO1, the expression of the proliferation-related genes cyclin D1, Mcm2 and PCNA in MM cells was determined by qRT-PCR and western blot assay. The protein level of p-Erk1/2 and MIF was determined by western blot assay and ELISA, respectively.
RESULTS: The expression levels of USO1 and MIF in MM tissues and cells were much higher than those in normal bone marrow tissues and cells. Knockdown of USO1 resulted in the inhibited ability of cell proliferation and induced cell apoptosis. The expression of cyclin D1, Mcm2, PCNA and p-Erk1/2 decreased significantly after knockdown of USO1 as well as the decreased MIF secretion.
CONCLUSION: USO1 gene may be a promising target for the therapy of human MM and its diagnosis marker.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cell proliferation; MIF; Multiple myeloma; USO1; p-Erk1/2

Mesh:

Substances:

Year:  2016        PMID: 26898451     DOI: 10.1016/j.biopha.2016.01.012

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

Review 1.  Golgi Complex: A Signaling Hub in Cancer.

Authors:  Daniela Spano; Antonino Colanzi
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

2.  High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (ERK1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.

Authors:  Liping Fan; Jinquan Hong; Haobo Huang; Danhui Fu; Shunquan Wu; Qingqing Wang; Yamei Ye; Yun Liu
Journal:  Med Sci Monit       Date:  2017-05-30

3.  Lambda-Carrageenan Enhances the Effects of Radiation Therapy in Cancer Treatment by Suppressing Cancer Cell Invasion and Metastasis through Racgap1 Inhibition.

Authors:  Ping-Hsiu Wu; Yasuhito Onodera; Frances C Recuenco; Amato J Giaccia; Quynh-Thu Le; Shinichi Shimizu; Hiroki Shirato; Jin-Min Nam
Journal:  Cancers (Basel)       Date:  2019-08-16       Impact factor: 6.575

4.  Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).

Authors:  Yan Dong; Liyan Xue; Yan Zhang; Caiyun Liu; Yanguang Zhang; Na Jiang; Xiaoyan Ma; Fangyu Chen; Lingxia Li; Liyuan Yu; Xuefeng Liu; Shujuan Shao; Shufang Guan; Jian Zhang; Qingchun Xiao; Hui Li; Ailing Dong; Lijie Huang; Chenyang Shi; Yan Wang; Ming Fu; Ning Lv; Qimin Zhan
Journal:  J Exp Clin Cancer Res       Date:  2022-04-21

5.  USO1 expression is dysregulated in non-small cell lung cancer.

Authors:  Anna Keogh; Lisa Ryan; Mutaz M Nur; Anne-Marie Baird; Siobhan Nicholson; Sinéad Cuffe; Gerard J Fitzmaurice; Ronan Ryan; Vincent K Young; Stephen P Finn; Steven G Gray
Journal:  Transl Lung Cancer Res       Date:  2022-09

6.  Focused CRISPR-Cas9 genetic screening reveals USO1 as a vulnerability in B-cell acute lymphoblastic leukemia.

Authors:  Amit Kumar Jaiswal; Hellen Truong; Tiffany M Tran; Tasha L Lin; David Casero; Michael O Alberti; Dinesh S Rao
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.